Dr. Bari specializes in the neurosurgical repair and restoration of brain and nerve function. Following his neurosurgery residency training at UCLA, Dr. Bari was awarded the prestigious William P. Van Wagenen Fellowship to train at the world-renowned functional neurosurgery program at the University of Toronto. He has extensive clinical and research experience in the use of deep brain stimulation (DBS) in the treatment of both movement and psychiatric disorders. Dr. Bari’s clinical practice includes DBS surgery for Parkinson’s disease, tremor, dystonia, depression and OCD. In addition, his clinical practice includes neurosurgery for brain tumors, pain, and peripheral nerve disorders.
Dr. Bari’s research focuses on an interdisciplinary approach to studying the neurobiology underlying movement and psychiatric disorders and expanding the frontiers of neurosurgery to treat those disorders. As a part of his fellowship training, Dr. Bari studied the relationship between the motor and reward systems of the brain and the use of deep brain stimulation to modify and enhance them. A native of California, Dr. Bari completed his neurosurgery residency training at UCLA after receiving his MD and PhD degrees from Boston University. He completed his undergraduate training at UC Berkeley in the field of neurobiology.
Biography
Christopher Evans received his Ph.D. from Imperial College London, conducting his thesis research on endorphins and enkephalins, at the Medical Research Council Institute in Mill Hill. After a postdoctoral fellowship at Stanford University, Dr. Evans joined the UCLA faculty in the Department of Psychiatry and Biobehavioral Science. His research accomplishments have included identification of a number of novel endogenous opioid peptides and the cloning of the first opioid receptor. Dr. Evans was Director of the UCLA Brain Research Institute from 2004-2017 and is the Stefan Hatos Professor directing the Shirley and Stefan Hatos Center for Neurophamacology in the UCLA Semel Institute. Dr. Evans is also director of a NIH-funded center – The Center for Opioid Receptors and Drugs of Abuse or CSORDA. CSORDA, with continuous NIH funding for over 30 years. The aims of CSORDA are to understand the action of opioid drugs such as morphine and heroin at the molecular, cellular and behavioral levels.
Publications
View a up-to-date publication list: https://pubmed.ncbi.nlm.nih.gov/collections/48826753/?sort=date
A selected list of publications:
Biography
Michael S. Fanselow is a Professor in the Department of Psychology at U.C.L.A. and has held academic appointments at Rennselaer Polytechnic Institute and Dartmouth College before coming to UCLA in 1987. He received his Ph.D. from the University of Washington and received the Edwin B Newman Award for Excellence in Research for his dissertation work there. He has also received the Early Career Distinguished Scientific Contribution Award and the D. O. Hebb Award from the American Psychological Association and the Troland Award from the National Academy of Science. He was elected President of the American Psychological Association’s Division of Behavioral Neuroscience and Comparative Psychology and President of the Pavlovian Society. He currently holds positions as the Staglin Family Chair and the Director of the Staglin Music Festival Center for Brain & Behavioral Health.